Klaus Okkenhaug

29PUBLICATIONS
168CO-AUTHORS
MechanobiologyHaematological tumoursSolid tumoursPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jan 16, 2026
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.

Alberto G Conti, Alexander C Evans, Teresa von Linde

|Apr 26, 2025
Perturbing local steroidogenesis to improve breast cancer immunity.

Qiuchen Zhao, Jhuma Pramanik, Yongjin Lu

|Mar 05, 2025
Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity.

Jie Yang, Yumi Yamashita-Kanemaru, Benjamin I Morris

|Feb 10, 2025
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses.

Puspendu Sardar, Benjamin S Beresford-Jones, Wangmingyu Xia

|Jul 05, 2024
PI3K Inhibitors in Hematology: When One Door Closes….

Sigrid S Skånland, Klaus Okkenhaug, Matthew S Davids

Pageof 5